Cybersecurity on tap for ransomware threat
The FDA's latest cybersecurity workshop was inevitably topical, given the rapidly shifting range of threats to device security, but the workshop took place as the Wannacry ransomware crippled hospitals around the world, making this a uniquely relevant event for the agency's efforts to ensure device cybersecurity and, by implication, patient safety.
Shares of med-tech firms surge as investors warm to sector, driven by optimism
Like their biopharmaceutical colleagues, publicly listed medical technology companies have roared out of the gate this year as investors flood back into health care. Companies have benefited from record-breaking market highs being driven by a increased optimism that the U.S. economy is poised to enjoy better times ahead.
Device deals climb with a focus on cancer, cardiovascular markets
The number of medical device deals and their disclosed values appear to be rising, according to data from Cortellis Deals Intelligence (CDI). CDI reported 202 med-tech deals in 2014, compared with 237 deals in 2015 and 287 deals in 2016. The total value of deals was $22.85 million in 2014, $251.06 million in 2015 and $1.54 billion in 2016.